Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatiscaseinolytic protease P




Objective


The objective of the study was to assess antibodies against Chlamydia trachomatis heat shock proteins (HSP) in patients with tubal factor infertility (TFI), infertility controls (IFC), and fertile controls (FC). HSPs assist organisms in surviving caustic environments such as heat.


Study design


Twenty-one TFI, 15 IFC, and 29 FC patients were enrolled after laparoscopic tubal assessment. The titers of antibodies against C trachomatis organisms and 14 chlamydial HSPs were compared among the 3 groups.


Results


TFI patients developed significantly higher levels of antibodies against C trachomatis and specifically recognizing chlamydial HSP60 and caseinolytic protease (Clp) P, a subunit of the ATP-dependent Clp protease complex involved in the degradation of abnormal proteins.


Conclusion


In addition to confirming high titers of antibodies against C trachomatis organisms and HSP60 in TFI patients, we identified a novel link of TFI with anti-ClpP antibodies. These findings may provide useful information for developing a noninvasive screening test for TFI and constructing subunit anti- C trachomatis vaccines.


Chlamydia trachomatis is the most common reported agent of sexually transmitted infections worldwide. The rate of C trachomatis infection in the United States has increased significantly over the last 2 decades. Infection with C trachomatis poses serious health risks, including long-term reproductive tract sequelae such as infertility, chronic pelvic pain, ectopic pregnancy, and development of cervical cancer.


The linkage of tubal factor infertility (TFI) to C trachomatis infection has been extensively studied. C trachomatis organisms can be isolated from a large portion of women with TFI and elevated anti– C trachomatis antibodies can be detected in more than 70% of women with tubal occlusion. Women with prior C trachomatis infection usually maintain high titers of C trachomatis antibodies. Although urogenital tract infections with C trachomatis is common and has been recognized as a significant cause of tubal infertility, the pathogenic mechanisms of C trachomatis –induced tubal damage remain unknown and no effective vaccines are available.


It has been hypothesized that host responses triggered by chlamydial infection contribute to both protective immunity and pathogenesis. Antibodies against the chlamydial major outer membrane protein (MOMP) are associated with protective host immune responses, which is consistent with the recent findings that immunization with a native MOMP-induced protection. In contrast, antibodies to chlamydial heat shock protein (HSP) 60 are associated with pathologies, which may provide a partial explanation for the half-century-old observation that whole chlamydial organism-based vaccines designed for preventing trachoma in children actually exacerbated pathologies. HSPs assist organisms in surviving stressful environments such as acidity or heat.


Our objective was to test whether human antibodies against other C trachomatis HSPs are also associated with chlamydia-induced tubal pathologies by comparing all 14 chlamydial HSPs for their reactivity with antibodies in patients with TFI, infertility controls (IFC), and fertile controls (FC).


Materials and Methods


Human antisera


Following approval by the institutional review board at the University of Texas Health Science Center at San Antonio, 21 TFI, 15 IFC, and 29 FC patients were enrolled. All recruited women underwent diagnostic laparoscopy with chromotubation. Diagnosis of tubal infertility was based on 1 of the following findings: hydrosalpinx, fimbrial phimosis, or peritubal adhesions. Women with prior tubal ligation or a history of pelvic infection or inflammation other than pelvic inflammatory disease such as appendicitis were excluded. IFC patients were women with normal pelvic findings and tubal patency at laparoscopy. FC patients had no history of infertility with at least 1 live birth and normal pelvic findings at time of tubal ligation. All participants underwent a single blood draw. Serum samples were stored at –20°C until analyzed.


Cell culture and chlamydial infection


HeLa cells (American Type Culture Collection, Manassas, VA) were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco PRL, Rockville, MD) with 10% fetal calf serum (FCS; Gibco BRL) at 37°C with 5% carbon dioxide (CO 2 ) as previously described. C trachomatis serovar D or C pneumoniae AR39 organisms were grown, purified, and titrated as previously described.


After titration, organisms were stored at –80°C. For immunofluorescence assay, chlamydial organisms were used to infect HeLa cells grown on glass coverslips in 24-well plates. The subconfluent HeLa cells were treated with DMEM containing 30 μg/mL of diethylaminoethyl (DEAE)-dextran (Sigma, St Louis, MO) for 10 minutes. After removal of DEAE-dextran solution, chlamydial organisms were added to the wells for 2 hours at 37°C. The infected cells were continuously cultured in DMEM with 10% FCS and 2 μg/mL of cycloheximide (Sigma).


For preparing whole-cell lysates, infection was carried out in tissue culture flasks. Infected cultures were processed or harvested 48 hours after infection or as indicated in individual experiments.


Immunofluorescence assay


Antichlamydial organism antibodies in human sera were titrated using an immunofluorescence assay as previously described. Briefly, HeLa cells grown on coverslips were infected with C trachomatis or C pneumoniae organisms, fixed 48 hours after infection for C trachomatis and 72 hours for C pneumoniae with 2% paraformaldehyde, and permeabilized with 2% saponin. After blocking, human antisera were added to the chlamydia-infected cell samples. Goat antihuman immunoglobulin (Ig) G conjugated with Cy2 (green; Jackson ImmunoResearch Laboratories, Inc, West Grove, PA) was used to visualize human antibody binding and a Hoechst deoxyribonucleic acid (DNA) dye (blue; Sigma) to visualize HeLa and chlamydial DNA. The highest dilution of a serum that still gave a positive reactivity was defined as the titer of the given serum sample.


All human serum samples were serially diluted, and the appropriate dilutions were repeated multiple times based on the results obtained from prior dilutions to obtain a more accurate titer for each serum. For the time-course study, the C trachomatis –infected HeLa cells were processed as described above at various time points after infection as indicated in the data figure.


The processed samples were coimmunostained with a mouse anti-HSP60 (unpublished data) or anti-caseinolytic protease (Clp) P (unpublished data) plus rabbit anti– C trachomatis serovar D organisms. The primary antibody binding was visualized with a goat antimouse IgG conjugated with Cy3 (red) and a goat antirabbit IgG conjugated with Cy2 (green; both from Jackson ImmunoResearch Laboratories), respectively, and DNA by a Hoechst DNA dye.


Images were acquired with an Olympus AX70 fluorescence microscope equipped with multiple filter sets (Olympus, Melville, NY) as previously described. All microscopic images were processed using an Adobe Photoshop program (Adobe Systems, San Jose, CA).


Chlamydial fusion protein–arrayed microplate enzyme-linked immunosorbent assay (ELISA)


The glutathione S -transferase (GST) fusion protein ELISA for detecting human antibody recognition of chlamydial proteins was carried as previously described. The bacterial lysates containing individual chlamydial GST fusion proteins were added to 96-well microplates precoated with glutathione (Pierce, Rockford, IL).


The GST fusion protein lysates included all 14 chlamydial HSP family members: GST-CT110 (GroEL, HSP60); GST-CT111 (GroES, HSP10); GST-CT113 (ClpB, ClpB-related ATP-dependent protease); GST-CT286 (ClpC, Clp protease ATP-binding subunit); GST-CT341 (DnaJ protein); GST-CT395 (GrpE, HSP70 cofactor); GST-CT396 (DnaK, HSP70); GST-CT407 (DksA, probable DnaK suppressor); GST-CT431 (ClpP, ATP-dependent ClpP endopeptidase); GST-CT604 (GroEL, HSP60); GST-CT705 (ClpX, ATP-dependent ClpX-related protease; GST-CT706 (ClpP, ATP-dependent ClpP endopeptidase subunit); GST-CT709 (MreB, Rod shape determining protein MreB/HSP70 sugar kinase); and GST-CT755 (HSP60).


Lysates containing GST alone, as negative, and GST-chlamydial protease-like activity factor, as positive controls, were also included. After blocking, human antisera preabsorbed with a bacterial lysates containing GST alone were reacted with the plate-immobilized fusion proteins. The human antibody reactivity was detected with a goat antihuman-IgG conjugated with horseradish peroxidase (HRP; Jackson ImmunoResearch Laboratories) plus the substrate 2,2′-azino-bi(2-ethylbenzothiazoline-6-sulforic acid) diammonium salt (ABTS; Sigma). The optical density (OD) was measured at 405 nm using a microplate reader (Molecular Devices Corp, Sunnyvale, CA).


To confirm the antibody-binding specificity, all antisera were further absorbed with lysates made from either HeLa cells alone or C trachomatis serovar D–infected HeLa cells prior to reacting with the fusion protein-coated plates. The antibody binding that remained positive after HeLa-alone lysate absorption but significantly reduced by chlamydia-HeLa lysate absorption was considered true positive.


Western blot


Western blot with GST fusion proteins as antigens was carried out as previously described. GST fusion proteins (GST-HSP60, GST-HSP10, GST-ClpP) were purified from the corresponding bacterial lysates using glutathione agarose beads as previously described. The purified fusion proteins were resolved on a sodium dodecyl sulfate-polyacrylamide gel and transferred to a nitrocellulose membrane. Membrane-immobilized proteins were reacted with human sera pooled from each patient group and preabsorbed with bacterial lysates containing GST alone. Human antibody binding was detected with a goat antihuman IgG-HRP secondary antibody and visualized with an enhanced chemiluminescence kit (Santa Cruz Biotechnology, Inc, Santa Cruz, CA).


Data analyses


Data were analyzed using SPSS version 15.0 software (IBM, Chicago, IL). As a preliminary step, titer values were log transformed to produce a normal distribution and analyses were performed on transformed values. Analysis of variance was used to assess anti- C trachomatis and anti- C pneumoniae antibodies to evaluate overall mean differences among the 3 groups of patients.


The Student t test was utilized to compare differences between groups. Because the antibody titers had large variations within a given group, the serum titers were evaluated by ranges of less than 1:10 (negative), 1:10 to 1:10,000 (low), and greater than 1:10,000 (high). The χ 2 and Fisher’s exact tests were used to compare TFI, IFC, and FC overall antibodies to C trachomatis and antibodies to C pneumoniae .


Finally, we evaluated pairwise differences between TFI vs IFC, TFI vs FC, and FC vs IFC in C trachomatis using logistic regression. ELISA results were analyzed also using χ 2 and Fisher’s exact tests as appropriate.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 21, 2017 | Posted by in GYNECOLOGY | Comments Off on Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatiscaseinolytic protease P

Full access? Get Clinical Tree

Get Clinical Tree app for offline access